As much as I agree that HA-I is not getting enough value ascribed to it, I'm not sure about the assumption that HA-I will jump to $500M.
Irinotecan had $900M sales until generics entered the market, so would have dropped back from there. You need to allow for % market penetration, risk of failure, time to market, partnering or production cost, etc.
That said, even if you're 500% optimistic, HA-I still carries significant value not currently recognised by the market. A Phase III trial will push it onto the stage.
- Forums
- ASX - By Stock
- TSN
- lets get real
TSN
the sustainable nutrition group ltd
Add to My Watchlist
0.00%
!
1.0¢

lets get real, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
VMM
VIRIDIS MINING AND MINERALS LIMITED
Rafael Moreno, CEO
Rafael Moreno
CEO
SPONSORED BY The Market Online